Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
Read the original report
Opens CNBC in a new tab
More on this deskAll BIZ
Where's the growth? Legacy automakers face a tougher 2027 as costs rise, market tightens
Automakers are warning about higher commodity, logistics and memory costs, while pricing power is becoming harder to extend to consumers.
PM tells firms to publish salaries in job adverts ahead of new law
The government argues the change will help jobseekers and could help to prevent pay discrimination.
Small retailers brace for 'huge hit' this holiday season as shipping costs spike
As shipping costs surge due to high fuel prices, smaller and medium-sized retailers struggle to keep up, and they face a difficult holiday season.
The engine parts that 'fight the laws of the universe'
Investment has surged into the making of jet turbine blades - an extremely difficult component to make.